当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析

华熙生物

(688363)

  

流通市值:121.88亿  总市值:296.23亿
流通股本:1.98亿   总股本:4.82亿

华熙生物(688363)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润2.43亿元,每股收益0.51元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益712733.29万元,未分配利润269725.19万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产831539.09万元,负债118805.79万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,360,531,9156,075,923,853.744,221,434,960.63,075,611,629.22
营业总成本1,042,739,955.345,438,234,078.173,695,744,556.372,625,933,511.09
营业利润300,319,112.92708,385,550.59611,164,707.27517,609,890.03
利润总额300,604,668.35701,722,462.64610,427,459.6516,630,011.16
净利润243,387,652.32582,742,033.51507,082,977.92421,561,907.33
其他综合收益-9,119,542.0628,665,320.957,791,296.7920,336,182.59
综合收益总额234,268,110.26611,407,354.46514,874,274.71441,898,089.92
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,839,514,084.843,122,855,256.253,207,373,119.43,314,356,200.64
非流动资产合计5,475,876,773.315,347,153,037.585,142,190,416.595,053,965,982.74
资产总计8,315,390,858.158,470,008,293.838,349,563,535.998,368,322,183.38
流动负债合计902,649,364.261,220,791,687.051,109,576,607.321,215,612,339.56
非流动负债合计285,408,577.8265,789,863.44265,805,314.69244,295,056
负债合计1,188,057,942.061,486,581,550.491,375,381,922.011,459,907,395.56
归属于母公司股东权益合计7,087,986,444.986,944,100,603.156,926,287,411.686,856,249,478.17
股东权益合计7,127,332,916.096,983,426,743.346,974,181,613.986,908,414,787.82
负债和股东权益合计8,315,390,858.158,470,008,293.838,349,563,535.998,368,322,183.38
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,380,453,113.826,820,494,614.694,679,989,275.123,389,927,222.39
经营活动现金流出小计1,345,601,845.616,120,846,413.474,445,100,057.063,203,501,887.16
经营活动产生的现金流量净额34,851,268.21699,648,201.22234,889,218.06186,425,335.23
投资活动现金流入小计342,138,879.041,806,347,467.511,470,210,836.631,338,726,143.89
投资活动现金流出小计397,083,821.512,419,229,490.981,848,807,483.971,522,454,912.3
投资活动产生的现金流量净额-54,944,942.47-612,882,023.47-378,596,647.34-183,728,768.41
筹资活动现金流入小计-57,714,817.5851,717,222.5851,717,222.58
筹资活动现金流出小计220,205,324.86585,281,313.67465,544,885.63437,053,896.61
筹资活动产生的现金流量净额-220,205,324.86-527,566,496.09-413,827,663.05-385,336,674.03
汇率变动对现金及现金等价物的影响-1,528,348.1510,564,999.387,198,775.6514,359,053.67
现金及现金等价物净增加额-241,827,347.27-430,235,318.96-550,336,316.68-368,281,053.54
期末现金及现金等价物余额571,232,634.73813,059,982692,958,984.28875,014,247.42
最新报告期:2024-04-30
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中金公司徐卓楠1.762.46--2024-04-30
国信证券柳旭,张峻豪1.892.332.812024-04-30
华泰证券代雯,孙茗馨,沈卢庆1.872.262.852024-04-30
开源证券黄泽鹏1.772.242.822024-04-30
东吴证券吴劲草,张家璇1.511.762.102024-04-30
TOP↑